Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic swine

Circulation: Cardiovascular Interventions

Volumn 4, Issue 5, 2011, Pages 447-455

  Granada, Juan F ^a   Milewski, Krzysztof ^a   Zhao, Hugh ^b   Stankus, John J ^b   Tellez, Armando ^a   Aboodi, Michael S ^a   Kaluza, Greg L ^a   Krueger, Christian G ^c   Virmani, Renu ^d   Schwartz, Lewis B ^b   Nikanorov, Alexander ^b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b ABBOTT VASCULAR   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d CVPATH INSTITUTE   (United States)

Author keywords

Angioplasty balloon; Hypercholesterolemic swine; Peripheral vascular disease; Restenosis; Zotarolimus

Indexed keywords

ZOTAROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL REACTIVITY; DRUG COATING; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TISSUE LEVEL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOGARTY CATHETER; HISTOPATHOLOGY; LOW DRUG DOSE; MORPHOMETRICS; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SUPERFICIAL FEMORAL ARTERY STENOSIS; SWINE;

ANGIOPLASTY, BALLOON; ANIMALS; BALLOON DILATION; CLINICAL PROTOCOLS; FEMORAL ARTERY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFUSION PUMPS, IMPLANTABLE; MODELS, ANIMAL; NEOINTIMA; POSTOPERATIVE COMPLICATIONS; SIROLIMUS; SWINE; TOR SERINE-THREONINE KINASES;

EID: 82955229559     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.110.960260     Document Type: Article

References (28)

1. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. (Pubitemid 351240748)
2. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
3. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005;112:270-278. (Pubitemid 40982311)
4. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006; 47:175-181. (Pubitemid 43005183)
5. Virmani R, Kolodgie FD, Farb A. Drug-eluting stents: are they really safe? Am Heart Hosp J. 2004;2:85-88.
6. Jabara R, Chronos N, Tondato F, Conway D, Molema W, Park K, Mabin T, King S, Robinson K. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries. J Invasive Cardiol. 2006;18:383-390. (Pubitemid 44178975)
7. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-814. (Pubitemid 39096008)
8. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. Neointima inhibition: comparison of effectiveness of nonstent- based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology. 2006;240:411-418. (Pubitemid 44098636)
9. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxelcoated balloon catheter. N Engl J Med. 2006;355:2113-2124. (Pubitemid 44749319)
10. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119: 2986-2994.
11. Cremers B, Biedermann M, Mahnkopf D, Bohm M, Scheller B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol. 2009;98:325-330.
12. Chen YW, Smith ML, Sheets M, Ballaron S, Trevillyan JM, Burke SE, Rosenberg T, Henry C, Wagner R, Bauch J, Marsh K, Fey TA, Hsieh G, Gauvin D, Mollison KW, Carter GW, Djuric SW. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression. J Cardiovasc Pharmacol. 2007;49:228-235. (Pubitemid 46626015)
13. Burke SE, Kuntz RE, Schwartz LB. Zotarolimus (abt-578) eluting stents. Adv Drug Deliv Rev. 2006;58:437-446. (Pubitemid 43833332)
14. Brugaletta S, Burzotta F, Sabate M. Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective. Expert Opin Pharmacother. 2009;10:1047-1058.
15. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, Rapacz J. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet. 1998;76:379-386. (Pubitemid 28163058)
16. Prescott MF, McBride CH, Hasler-Rapacz J, Von Linden J, Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol. 1991;139:139-147.
17. Granada JF, Kaluza GL, Wilensky RL, Biedermann BC, Schwartz RS, Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention. 2009;5: 140-148.
18. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645. (Pubitemid 27329445)
19. Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Bohm M, Stoll HP. Contrast media as carriers for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J. 2003;24:1462-1467. (Pubitemid 36961837)
20. Scheller B, Speck U, Schmitt A, Bohm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003;42:1415-1420. (Pubitemid 37267283)
21. Sollott SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG, Rowinsky EK. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 1995;95:1869-1876.
22. Cremers B, Toner JL, Schwartz LB, Von Oepen R, Speck U, Kaufels N, Clever YP, Mahnkopf D, Bohm M, Scheller B. Inhibition of coronary neointimal hyperplasia in swine using a novel zotarolimus-eluting balloon catheter. Eur Heart J. 2009;30(suppl):532.
23. Gray WA, Granada JF. Drug-coated balloons for the prevention of vascular restenosis. Circulation. 2010;121:2672-2680.
24. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NA, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv. 2008;1:143-153.
25. Thim T, Hagensen MK, Drouet L, Bal Dit Sollier C, Bonneau M, Granada JF, Nielsen LB, Paaske WP, Botker HE, Falk E. Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention. 2010;6:261-268.
26. Mori E, Komori K, Yamaoka T, Tanii M, Kataoka C, Takeshita A, Usui M, Egashira K, Sugimachi K. Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation. 2002;105:2905-2910. (Pubitemid 34666106)
27. Tanaka H, Sunamori M, Suzuki A, Sukhova GK, Libby P. Endothelial activation potentiates neointimal lesion formation in the rabbit aorta after balloon injury. Ann N Y Acad Sci. 1997;811:448-458. (Pubitemid 27308352)
28. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K, Sueishi K. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res. 1998;82: 147-156. (Pubitemid 28080097)